Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program
published in: Multiple Sclerosis Journal
date of publication: 2020-06-24
main subject: relapsing-remitting multiple sclerosis
Cites articles
There is nothing here
Article - wd:Q96648482